Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

Dopaminergic pathway is the most disrupted pathway in the pathogenesis of Parkinson's disease. Several studies reported associations of dopaminergic genes with the occurrence of adverse events of dopaminergic treatment. However, none of these studies adopted a pathway based approach. The aim of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Redenšek, Sara, Flisar, Dušan, Kojović, Maja, Gregorič Kramberger, Milica, Georgiev, Dejan, Pirtošek, Zvezdan, Trošt, Maja, Dolžan, Vita
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6360186/
https://ncbi.nlm.nih.gov/pubmed/30745869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00008
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki